1. Home
  2. SII vs BLFS Comparison

SII vs BLFS Comparison

Compare SII & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SII
  • BLFS
  • Stock Information
  • Founded
  • SII 2008
  • BLFS 1987
  • Country
  • SII Canada
  • BLFS United States
  • Employees
  • SII N/A
  • BLFS N/A
  • Industry
  • SII Finance: Consumer Services
  • BLFS Medical/Dental Instruments
  • Sector
  • SII Finance
  • BLFS Health Care
  • Exchange
  • SII Nasdaq
  • BLFS Nasdaq
  • Market Cap
  • SII 1.1B
  • BLFS 1.0B
  • IPO Year
  • SII N/A
  • BLFS 1989
  • Fundamental
  • Price
  • SII $68.80
  • BLFS $21.64
  • Analyst Decision
  • SII
  • BLFS Strong Buy
  • Analyst Count
  • SII 0
  • BLFS 7
  • Target Price
  • SII N/A
  • BLFS $30.57
  • AVG Volume (30 Days)
  • SII 182.9K
  • BLFS 622.4K
  • Earning Date
  • SII 08-06-2025
  • BLFS 08-07-2025
  • Dividend Yield
  • SII 1.67%
  • BLFS N/A
  • EPS Growth
  • SII 10.23
  • BLFS N/A
  • EPS
  • SII 1.93
  • BLFS N/A
  • Revenue
  • SII $180,474,000.00
  • BLFS $87,762,000.00
  • Revenue This Year
  • SII $0.57
  • BLFS $21.21
  • Revenue Next Year
  • SII $8.89
  • BLFS $17.58
  • P/E Ratio
  • SII $35.66
  • BLFS N/A
  • Revenue Growth
  • SII 17.97
  • BLFS 34.80
  • 52 Week Low
  • SII $38.41
  • BLFS $18.70
  • 52 Week High
  • SII $69.00
  • BLFS $29.55
  • Technical
  • Relative Strength Index (RSI)
  • SII 81.04
  • BLFS 44.20
  • Support Level
  • SII $63.33
  • BLFS $20.50
  • Resistance Level
  • SII $65.97
  • BLFS $22.07
  • Average True Range (ATR)
  • SII 1.43
  • BLFS 1.02
  • MACD
  • SII 0.13
  • BLFS -0.10
  • Stochastic Oscillator
  • SII 87.47
  • BLFS 22.69

About SII Sprott Inc.

Sprott Inc is an alternative asset manager. The company has four reportable segments: Exchange Listed Products, which derives key revenue, and includes management services to the company's closed-end physical trusts and exchange-traded funds, both of which are actively traded on public securities exchanges; Managed equities segment provides asset management and sub-advisory services to the company's branded funds, fixed-term LPs and managed accounts; Private strategies which provide lending and streaming activities through limited partnership vehicles; and the Corporate segment which provides capital, balance sheet management and enterprise shared services to the company's subsidiaries. Geographically, it derives key revenue from Canada, followed by the United States.

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

Share on Social Networks: